Webcast Alert: Aastrom Biosciences Announces Its Fourth Quarter and Fiscal Year End Investor Conference Call
07 September 2005 - 10:00PM
Business Wire
Aastrom Biosciences (NASDAQ: ASTM) announces the following Webcast:
-0- *T What: Aastrom Biosciences Fourth Quarter and Fiscal Year End
FY2005 Investor Conference Call When: Thursday, September 8, 2005 @
11:00 AM Eastern Where: http://www.vcall.com/EventPage.asp?ID=94806
How: Live over the Internet -- Simply log on to the web at the
address above. Interested parties should call toll-free (877)
407-9205, or from outside the U.S. (201) 689-8054. Contact:
Investor Relations Department, (734) 930-5777 or mail@aastrom.com
*T If you are unable to participate during the live webcast, the
call will be available for replay at
http://www.vcall.com/ClientPage.asp?ID=94806 or
http://www.investorcalendar.com/ Aastrom Biosciences, Inc. (Nasdaq:
ASTM) is developing patient-specific products for the repair or
regeneration of human tissues, utilizing the Company's proprietary
adult stem cell technology. Aastrom's strategic position in the
tissue regeneration sector is enabled by its proprietary Tissue
Repair Cells (TRCs), a mix of bone marrow-derived adult stem and
progenitor cells, and the AastromReplicell(R) System, an
industry-unique automated cell production platform used to produce
cells for clinical use. TRCs are the core component of the products
Aastrom is developing for severe bone fractures, ischemic vascular
disease, jaw reconstruction and spine fusion, with Phase I/II level
clinical trials active in the U.S. and EU for some of these
indications. For more information, visit Aastrom's website at
www.aastrom.com.
Vericel (NASDAQ:VCEL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Vericel (NASDAQ:VCEL)
Historical Stock Chart
From Jul 2023 to Jul 2024